Patent · US Active

Pharmaceutical use of thiophene [3,2-d] pyrimidine-4-ketone compound

US11730742B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES · CN

Inventors

Hong Liu · Shanghai, CN
Jia-He Li · Cockeysville, US
Jiang Wang · Shanghai, CN
Yi Zang · Princeton Junction, US
Jian Li · Shanghai, CN
Jingya Li · Gothenburg, SE
Dandan Sun · Hefei, CN
Hualiang Jiang · Shanghai, CN
Kaixian Chen · Shanghai, CN

Key dates

Filing date	Mar 8, 2019
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Sep 6, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is use of a thieno[3,2-d]pyrimidin-4-one compound represented by general formula (I). Definition of each substituent is as stated in the description and claims, and the compound is used for preparing medicines for treating and/or preventing liver fibrosis and related diseases or preparing a DPP-4 inhibitor, or is used as a DPP-4 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.